文献速递药疹与重症皮肤不良反应

基于颗粒溶素的淋巴细胞活化试验评估抗癫痫药致重症皮肤不良反应的药物因果关系

Granulysin-Based Lymphocyte Activation Test for Evaluating Drug Causality in Antiepileptics-Induced Severe Cutaneous Adverse Reactions.
PubMed 文献 · J Invest Dermatol · 2020-12-17

本研究纳入63例抗癫痫药所致皮肤不良反应患者和30例耐受对照,检测颗粒溶素、颗粒酶B和IFN-γ的淋巴细胞活化试验。颗粒溶素法对卡马西平敏感性73.9%、特异性96.7%,对苯妥英敏感性68.2%、特异性96.7%。该试验主要扩增记忆细胞毒性T细胞,可确认药物因果关系。

要点

  • 颗粒溶素法对卡马西平敏感性73.9%、特异性96.7%。
  • 颗粒溶素法对苯妥英敏感性68.2%、特异性96.7%。
  • 奥卡西平和拉莫三嗪抗原性弱。

核心结论

  • 基于颗粒溶素的淋巴细胞活化试验可反映体外细胞毒性T细胞记忆应答,有助于确认抗癫痫药所致重症皮肤不良反应的药物因果关系。

研究设计与样本

  • 研究纳入63例抗癫痫药所致皮肤不良反应患者(39例Stevens-Johnson综合征-中毒性表皮坏死松解症、13例药物反应伴嗜酸性粒细胞增多和全身症状、11例麻疹样药疹)和30例耐受对照。

主要发现

  • 颗粒溶素法对卡马西平敏感性73.9%、特异性96.7%,对苯妥英敏感性68.2%、特异性96.7%。
  • 奥卡西平和拉莫三嗪显示弱抗原性。
  • 颗粒溶素法主要扩增记忆细胞毒性T细胞,具有药物特异性T细胞受体、主要组织相容性复合体I依赖性和对不同芳香族抗癫痫药的交叉反应性。
  • 29例随访患者中28例改用非芳香族抗癫痫药,均未发生皮肤不良反应。

临床怎么用

  • 基于颗粒溶素的淋巴细胞活化试验可用于确认抗癫痫药所致重症皮肤不良反应的 culprits 药物。
  • 实施该试验有助于改善抗癫痫药所致重症皮肤不良反应的预防和临床管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Aromatic antiepileptic drugs (AEDs) are common causes of cutaneous adverse drug reactions, which range from morbilliform drug eruption to life-threatening severe cutaneous adverse reactions, including drug reaction with eosinophilia and systemic symptoms, Stevens‒Johnson syndrome, and toxic epidermal necrolysis. Different in vitro methods for identifying the culprit drugs have been developed; however, it is particularly challenging for Stevens‒Johnson syndrome-toxic epidermal necrolysis. In this study, we enrolled 63 patients (39 with Stevens‒Johnson syndrome-toxic epidermal necrolysis, 13 with drug reaction with eosinophilia and systemic symptoms, and 11 with morbilliform drug eruption) and 30 tolerant controls to examine the performance of lymphocyte activation tests by measuring the expression of granulysin, granzyme B, and IFN-γ. Granulysin-based lymphocyte activation tests displayed the best sensitivity and specificity to identify the causality: 73.9% sensitivity and 96.7% specificity for carbamazepine and 68.2% sensitivity and 96.7% specificity for phenytoin. Oxcarbazepine and lamotrigine show weak antigenicity. Granulysin-based lymphocyte activation tests expanded predominantly memory cytotoxic T lymphocytes with characteristics of drug-specific T-cell receptor, major histocompatibility complex I dependence, and cross reactivity to different aromatic AEDs. Among 29 follow-up patients, 28 alternatively used nonaromatic AEDs, and none developed cutaneous adverse drug reactions. Our data suggest that granulysin-based lymphocyte activation tests represent in vitro cytotoxic T-lymphocyte memory response to offending drugs and are useful to confirm drug causality of AED-induced severe cutaneous adverse reactions. Implementing these tests will improve the AED-induced severe cutaneous adverse reactions prevention and clinical care.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Chu MT, Wang CW, Chang WC, et al. Granulysin-Based Lymphocyte Activation Test for Evaluating Drug Causality in Antiepileptics-Induced Severe Cutaneous Adverse Reactions. J Invest Dermatol. 2020. PMID: 33340500. doi:10.1016/j.jid.2020.11.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。